The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...

Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...

Please provide your email address to receive an email when new articles are posted on . A 36-year-old Caucasian male presented with a chief complaint of mild blur in the left eye at distance and near ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

The eye condition, which can induce the loss of central vision, could see effective treatment options pending FDA approval. Macular telangiectasia (MacTel) has long gone without a consensus treatment ...

First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing ...

TORONTO, Ontario — The use of a topical ocular nonsteroidal anti-inflammatory drug (NSAID) before and after cataract surgery leads to meaningful reductions in postoperative macular edema in patients ...

Geographic atrophy (GA) is one of two kinds of advanced age-related macular degeneration (AMD). It’s an eye disease that damages cells in the central part of your retina called the macula. Late-stage ...

Diabetic retinopathy (DR) and diabetic macular edema (DME) are two common vision conditions related to diabetes. While both can lead to vision loss, they are different eye conditions. DR is a ...